Skip to main content

Table 2 Characteristics of studies included in the meta-analysis

From: Current evidences on XPC polymorphisms and gastric cancer susceptibility: a meta-analysis

First author (Year)

Country

Ethnicity

Sample size (case/control)

Genotyping methods

Matching criteria

Source of control

GC ascertainment

SNPs

HWE(P value)

Quality scores

         

Lys939Gln

Ala499Val

PAT+/−

 

Palli 2010

Italy

Caucasian

306/547

TaqMan

Gender

PB

Histo-

PAT+/−

—

—

0.085

7

Dong 2008

China

Asian

253/612

PCR-RFLP

Age and gender

PB

Histopatho-

Lys939Gln, Ala499Val, PAT+/−

0.699

0.217

0.786

8.5

Engin 2011

Turkey

Caucasian

106/116

PCR-RFLP

Age and BMI

HB

NR

Lys939Gln

0.642

—

—

4.5

Long 2010

China

Asian

361/616

TaqMan

Age, gender, ethnicity, smoking, and drinking

HB

Histopatho-

Lys939Gln, Ala499Val

0.446

0.673

—

6

Ye 2006

Sweden

Caucasian

126/472

PCR-RFLP

NR

PB

Histo-

Lys939Gln

0.540

—

—

7

Li 2010

China

Asian

203/210

PCR-RFLP

Age, gender, smoking, and drinking

HB

Patho-

Lys939Gln, Ala499Val

0.173

0.462

—

7.5

  1. GC, Gastric cancer; Histopatho-, Histopathologically confirmed; Histo-, Histologically confirmed; Patho-, Pathologically confirmed; NR, Not reported; PB, Population–based; HB, Hospital–based; HWE, Hardy–Weinberg equilibrium in control population; PCR–RFLP, Polymerase chain reaction-restriction fragment length polymorphism; BMI, Body mass index.